Jefferies reported on Tuesday that they have raised their price target for health care products company, Abbott Laboratories(ABT).
The firm, which currently has a “Buy” rating on ABT, has increased the company’s price target to $40. This price target suggests a 15% increase from the stock’s current price of $33.96.
Analysts have increased the company’s price target based on conservative guidance.
Abbott Laboratories shares were up 43 cents, or 1.28% during Tuesday morning trading. The stock has increased 23% in the past year.
The Bottom Line
Shares of Abbott Laboratories(ABT) have a 1.65% yield, based on Tuesday morning’s price of $33.96.
Abbott Laboratories(ABT) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.
FREE Dividend Stock Newsletter
Get the Dividend.com email newsletter to receive:
- A free copy of our acclaimed report, 5 Rules of Winning Dividend Stock Investing
- Free daily investing tips and picks from Dividend.com CEO Paul Rubillo
- Tons of great market analysis and recommendations